entertainment -WSS

entertainment

author：entertainment 2025-09-07 17:27:02 - browse：5

inflamed intestine on a dark blue background — biotech coverage from STAT — Adobe

What happens after you close a nearly $11 billion acquisition?

Well, for Prometheus Therapeutics’ former CEO Mark McKenna, there was a brief vacation. But within weeks of the company’s acquisition by Merck closing last June, he was thinking about ideas for the future.

Investors were floating ideas by him. McKenna discussed possibilities with his teenagers and Prometheus’ chief scientific officer. This “summer of discovery,” as McKenna called it, brought him back to the immune system. Prometheus and some other companies have been able to capitalize on creating treatments for conditions like inflammatory bowel disease and psoriasis, while arthritis medications like Humira have brought in billions of dollars in sales. But the field hadn’t quite received the same attention as missions to cure cancer.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Watch the official trailer for 'Ahsoka' series

WSS

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

EU fines Illumina $475 million over Grail acquisition

Alexander Hamilton and the argument for universal insurance

Biden to sign 'historic' executive order on how US military handles sexual assault cases

Grail's uphill battle for Medicare to cover its cancer screening test

The debate over Covid

leisure time

entertainment

leisure time

Alkermes shareholders re

After half a century, Israel moves to evict squatter from his cave home on the beach

Hepatitis C has a cure — but many Americans still lack access to it

'The boss' wants server deleted: New allegations emerge in Trump indictment

The cancer drug shortage isn’t new — and neither are the solutions

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Duchenne breakthrough therapy leaves behind pioneering families

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

As demand for Covid shots wanes, Moderna seeks its next success

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

focus

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

Inflation cooled significantly in June, bringing price hikes close to normal levels

Sickle cell gene therapy cures need to be accessible in Africa

Interest rates are at a 22

Interest rates are at a 22

Stoke drug shows lower activity against childhood epilepsy

knowledge

explore

focus

hotspot